[go: up one dir, main page]

AU2003235799A1 - Modulation of iamt (pimt or pcmt) in immune system - Google Patents

Modulation of iamt (pimt or pcmt) in immune system

Info

Publication number
AU2003235799A1
AU2003235799A1 AU2003235799A AU2003235799A AU2003235799A1 AU 2003235799 A1 AU2003235799 A1 AU 2003235799A1 AU 2003235799 A AU2003235799 A AU 2003235799A AU 2003235799 A AU2003235799 A AU 2003235799A AU 2003235799 A1 AU2003235799 A1 AU 2003235799A1
Authority
AU
Australia
Prior art keywords
iamt
pcmt
pimt
modulation
immune system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003235799A
Other versions
AU2003235799A8 (en
Inventor
Paul Andreas Compare Cloos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordic Bioscience AS
Original Assignee
Nordic Bioscience AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordic Bioscience AS filed Critical Nordic Bioscience AS
Publication of AU2003235799A1 publication Critical patent/AU2003235799A1/en
Publication of AU2003235799A8 publication Critical patent/AU2003235799A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/14—[b,f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003235799A 2002-01-08 2003-01-07 Modulation of iamt (pimt or pcmt) in immune system Abandoned AU2003235799A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US34670902P 2002-01-08 2002-01-08
US60/346,709 2002-01-08
DKPA200200026 2002-01-08
DKPA200200026 2002-01-08
PCT/EP2003/000079 WO2003057204A2 (en) 2002-01-08 2003-01-07 Modulation of iamt (pimt or pcmt) in immune system

Publications (2)

Publication Number Publication Date
AU2003235799A1 true AU2003235799A1 (en) 2003-07-24
AU2003235799A8 AU2003235799A8 (en) 2003-07-24

Family

ID=26069124

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003235799A Abandoned AU2003235799A1 (en) 2002-01-08 2003-01-07 Modulation of iamt (pimt or pcmt) in immune system

Country Status (2)

Country Link
AU (1) AU2003235799A1 (en)
WO (1) WO2003057204A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004290499C1 (en) 2003-11-03 2011-02-24 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
FR2862661B1 (en) * 2003-11-26 2007-10-05 Agronomique Inst Nat Rech USE OF L-ISOASPARTYL METHYLTRANSFERASE AS A MARKER FOR LONGEVITY OF SEEDS.
CA2554809C (en) 2004-02-05 2014-04-29 Probiodrug Ag Novel n-alkyl thiourea- and thioamide-substituted imidazolyl inhibitors of glutaminyl cyclase
JP5379692B2 (en) 2006-11-09 2013-12-25 プロビオドルグ エージー 3-Hydroxy-1,5-dihydro-pyrrol-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcers, cancer and other diseases
DK2091948T3 (en) 2006-11-30 2012-07-23 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
AU2008220785B2 (en) 2007-03-01 2013-02-21 Vivoryon Therapeutics N.V. New use of glutaminyl cyclase inhibitors
US9656991B2 (en) 2007-04-18 2017-05-23 Probiodrug Ag Inhibitors of glutaminyl cyclase
EP2475428B1 (en) 2009-09-11 2015-07-01 Probiodrug AG Heterocylcic derivatives as inhibitors of glutaminyl cyclase
JP6026284B2 (en) 2010-03-03 2016-11-16 プロビオドルグ エージー Inhibitors of glutaminyl cyclase
EA022420B1 (en) 2010-03-10 2015-12-30 Пробиодруг Аг Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
ES2570167T3 (en) 2011-03-16 2016-05-17 Probiodrug Ag Benzimidazole derivatives as glutaminyl cyclase inhibitors
ES2812698T3 (en) 2017-09-29 2021-03-18 Probiodrug Ag Glutaminyl cyclase inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3100207A (en) * 1959-07-08 1963-08-06 Smith Kline French Lab 10-aminoalkylbenzo[b,f]thiepin and -dibenz[b,f]oxepin derivatives
NL124626C (en) * 1964-06-29
CH440318A (en) * 1964-11-03 1967-07-31 Geigy Ag J R Process for the preparation of new thiepin and oxepine derivatives
US3641056A (en) * 1970-01-06 1972-02-08 Ciba Geigy Corp 10-(aminomethyl)- and (aminoethyl)-dibenz (b f)oxepins
ES2160790T3 (en) * 1995-02-08 2001-11-16 Novartis Ag 10-AMINOALIFATIL-DIBENZO (B, F) OXEPINS OF ANTINEURODEGENERATIVE ACTION.
AR008371A1 (en) * 1996-05-30 2000-01-19 Novartis Ag AN ADDITION SALT WITH ACID OF A 10-AMINOALIFATIL-DIBENZ [B, F], OXEPINE, YOUR EMPLOYMENT; PROCEDURE FOR ITS PREPARATION, A 10-AMINOALIFATIL-DIBENZ [B, F] OXEPINE, A PHARMACEUTICAL PREPARATION CONTAINING SUCH SALT OR SUCH OXEPINE AND A PROCEDURE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
WO1998015647A1 (en) * 1996-10-08 1998-04-16 Novartis Ag Modulation of apoptosis
US20020006653A1 (en) * 2000-04-28 2002-01-17 Meyers Rachel A. 25692, a novel human O-Methyltransferase family member and uses thereof
EP1311687A2 (en) * 2000-07-14 2003-05-21 Millennium Pharmaceuticals, Inc. Putative human methyltransferase family member and uses thereof
WO2002052016A2 (en) * 2000-12-26 2002-07-04 Bayer Aktiengesellschaft Regulation of human protein l-isoaspartate o-methyltransferase-like enzyme

Also Published As

Publication number Publication date
WO2003057204A2 (en) 2003-07-17
AU2003235799A8 (en) 2003-07-24
WO2003057204A3 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
AU2003284123A1 (en) Composition and filter system using the said composition
AU2002351414A1 (en) Backpack system
AU2003270592A1 (en) Anti-entrapment system
AU2003285810A1 (en) Vision system
AU2003289299A1 (en) Av system
AU2003221824A1 (en) Barge-mounted tidal-powered desalinization system
AU2003215285A1 (en) Hair-coloring system
AUPS020302A0 (en) Methods and systems (npw007)
AU2003268165A1 (en) Transit system
AU2003267279A1 (en) Systems and methods for transformable suits
AU2003299588A1 (en) Pipe-inspection system
AU2003218099A1 (en) Modulation of the immune response through the manipulation of arginine levels
AU2002309486A1 (en) Methods and compositions for modulating the immune system of animals
AU2003235799A1 (en) Modulation of iamt (pimt or pcmt) in immune system
AUPS048402A0 (en) Methods and systems (ap43)
AU2003255787A1 (en) Modulation of immune function
AU2003275368A1 (en) Prosthodontia system
AU2002345878A1 (en) Ilt3 and ilt4-related compositions and methods
AU2003269268A1 (en) Modulation of immune function
AU2003205303A1 (en) Photodetection system and circuit for amlification
AUPS047502A0 (en) Methods and systems (ap66)
AUPS048302A0 (en) Methods and systems (ap79)
AU2003271883A1 (en) Vector system
AUPS048202A0 (en) Methods and systems (ap78)
AU2003233712A1 (en) Eyewear and system

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase